Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group.

Van Gaal LF, Broom JI, Enzi G, Toplak H.

Eur J Clin Pharmacol. 1998 Apr;54(2):125-32.

PMID:
9626916
3.

First clinical studies with orlistat: a short review.

Drent ML, van der Veen EA.

Obes Res. 1995 Nov;3 Suppl 4:623S-625S. Review.

4.

Orlistat: its current status as an anti-obesity drug.

Ballinger A, Peikin SR.

Eur J Pharmacol. 2002 Apr 12;440(2-3):109-17. Review.

PMID:
12007529
5.

Review article: malnutrition and maltreatment--a comment on orlistat for the treatment of obesity.

Cahill A, Lean ME.

Aliment Pharmacol Ther. 1999 Aug;13(8):997-1002. Review.

6.

Orlistat: a review of its use in the management of obesity.

Hvizdos KM, Markham A.

Drugs. 1999 Oct;58(4):743-60. Review.

PMID:
10551441
7.

Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers.

Zhi J, Melia AT, Eggers H, Joly R, Patel IH.

J Clin Pharmacol. 1995 Nov;35(11):1103-8. Review.

PMID:
8626884
8.
9.

Orlistat.

McNeely W, Benfield P.

Drugs. 1998 Aug;56(2):241-9; discussion 250. Review.

PMID:
9711448
10.

Orlistat in the treatment of obesity.

Ballinger A.

Expert Opin Pharmacother. 2000 May;1(4):841-7. Review.

PMID:
11249520
11.

Obesity in transplant patients: case report showing interference of orlistat with absorption of cyclosporine and review of literature.

Barbaro D, Orsini P, Pallini S, Piazza F, Pasquini C.

Endocr Pract. 2002 Mar-Apr;8(2):124-6. Review.

PMID:
11942778
12.

Mode of action of orlistat.

Guerciolini R.

Int J Obes Relat Metab Disord. 1997 Jun;21 Suppl 3:S12-23. Review.

PMID:
9225172
13.

Orlistat: in the prevention and treatment of type 2 diabetes mellitus.

Keating GM, Jarvis B.

Drugs. 2001;61(14):2107-19; discussion 2120-1. Review.

PMID:
11735640
14.

Does orlistat cause acute kidney injury?

Beyea MM, Garg AX, Weir MA.

Ther Adv Drug Saf. 2012 Apr;3(2):53-7. doi: 10.1177/2042098611429985. Review.

Supplemental Content

Support Center